94 related articles for article (PubMed ID: 8768296)
1. [Erythropoietin in oncology. II. Evaluation of the effectiveness of erythropoietin in hematologic and oncologic diseases].
Adam Z; Krejcí M; Vorlícek J
Vnitr Lek; 1996 May; 42(5):351-8. PubMed ID: 8768296
[TBL] [Abstract][Full Text] [Related]
2. Recombinant human erythropoietin in the treatment of cancer-related or chemotherapy-induced anaemia in patients with solid tumours.
Nowrousian MR
Med Oncol; 1998 Aug; 15 Suppl 1():S19-28. PubMed ID: 9785333
[TBL] [Abstract][Full Text] [Related]
3. [Recombinant human erythropoietin in the treatment of anemia associated with lymphoproliferative diseases--chronic lymphadenosis and multiple myeloma].
Haber J; Spicka I; Petruzelka L; Kolesková E; Straub J; Jonásová A; Pospísilová B
Vnitr Lek; 1996 Apr; 42(4):262-7. PubMed ID: 8693713
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of treatment of anemia with erythropoietin in patients with multiple myeloma].
Adam Z; Krahulová M; Spelda S; Vorlícek J; Hejlová N; Hájek R; Tomíska M
Vnitr Lek; 1995 Nov; 41(11):767-72. PubMed ID: 8553596
[TBL] [Abstract][Full Text] [Related]
5. [Erythropoietin in the treatment of anemias].
Spicka I; Klener P; Lachmanová J; Háber J
Vnitr Lek; 1996 Mar; 42(3):197-9. PubMed ID: 8686210
[TBL] [Abstract][Full Text] [Related]
6. [Erythropoietin in hematology and oncology. I. Chronic anemia in malignant disease and the pharmacology of erythropoietin].
Adam Z; Krejcí M; Vorlícek J
Vnitr Lek; 1996 Apr; 42(4):285-9. PubMed ID: 8693717
[TBL] [Abstract][Full Text] [Related]
7. [Erythropoietin: a study of its use in oncohematology].
Fernández Martín JM; Villa Rubio A; Cameán Fernández M; Borrero Rubio JM; Martínez Díaz C; Díaz Navarro J; Moreno Sánchez FC; Serrano Ruiz FJ
Farm Hosp; 2004; 28(1):20-8. PubMed ID: 15012175
[TBL] [Abstract][Full Text] [Related]
8. [Tumor anemia. Overview of the role of human recombinant erythropoietin (r-hu-EPO) in treatment of tumor anemia].
Monnerat C; Leyvraz S
Praxis (Bern 1994); 1999 Jan; 88(5):178-88. PubMed ID: 10067375
[TBL] [Abstract][Full Text] [Related]
9. [Therapeutic use of recombinant human erythropoietin in clinical practice].
Scudla V
Vnitr Lek; 1995 Mar; 41(3):210-4. PubMed ID: 7762184
[TBL] [Abstract][Full Text] [Related]
10. [Updating 1999 of Standards, Options and Recommendations (SOR) for the clinical use of erythropoietin in oncology. FEDERATION OF THE FRENCH CANCER CENTRES (FNCLCC)].
Spaëth D; Marchal C; Bataillard A; Blanc-Vincent MP
Bull Cancer; 1999; 86(7-8):631-9. PubMed ID: 10477381
[TBL] [Abstract][Full Text] [Related]
11. [Erythropoietin or transfusion?].
Bártová V; Nĕmecek K; Lachmanová J
Vnitr Lek; 1993 May; 39(5):445-50. PubMed ID: 8351875
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of anemia in patients with chronic renal insufficiency with recombinant human erythropoietin].
Djukanović Lj; Lezaić V
Srp Arh Celok Lek; 1996; 124(3-4):93-7. PubMed ID: 9102827
[TBL] [Abstract][Full Text] [Related]
13. Prediction of response to treatment with recombinant human erythropoietin in anaemia associated with cancer.
Beguin Y
Med Oncol; 1998 Aug; 15 Suppl 1():S38-46. PubMed ID: 9785336
[TBL] [Abstract][Full Text] [Related]
14. Anaemia in cancer: pathophysiology and treatment.
Mercadante S; Gebbia V; Marrazzo A; Filosto S
Cancer Treat Rev; 2000 Aug; 26(4):303-11. PubMed ID: 10913385
[TBL] [Abstract][Full Text] [Related]
15. Beyond anaemia management: evolving role of erythropoietin therapy in neurological disorders, multiple myeloma and tumour hypoxia models.
Boogaerts M; Mittelman M; Vaupel P
Oncology; 2005; 69 Suppl 2():22-30. PubMed ID: 16244507
[TBL] [Abstract][Full Text] [Related]
16. [Anemia and chemotherapy of malignant hemopathies].
Damaj G; Braud AC; Hermine O
Bull Cancer; 2003 Apr; 90 Spec No():S144-51. PubMed ID: 12856426
[TBL] [Abstract][Full Text] [Related]
17. Anemia in the critically ill.
Shander A
Crit Care Clin; 2004 Apr; 20(2):159-78. PubMed ID: 15135458
[TBL] [Abstract][Full Text] [Related]
18. Recombinant human erythropoietin treatment of anemic cancer patients.
Henry DH
Cancer Pract; 1996; 4(4):180-4. PubMed ID: 8900758
[TBL] [Abstract][Full Text] [Related]
19. Preclinical and clinical effects of erythropoietin in the management of anaemia in patients with non-small cell lung cancer.
Dempke W
Anticancer Res; 2007; 27(4A):1745-57. PubMed ID: 17649769
[TBL] [Abstract][Full Text] [Related]
20. Adding growth factors or interleukin-3 to erythropoietin has limited effects on anemia of transfusion-dependent patients with myelodysplastic syndromes unresponsive to erythropoietin alone.
Musto P; Sanpaolo G; D'Arena G; Scalzulli PR; Matera R; Falcone A; Bodenizza C; Perla G; Carotenuto M
Haematologica; 2001 Jan; 86(1):44-51. PubMed ID: 11146570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
